Dichos y Refranes

Descargar Glaxo en DOCX

Glaxo DOCX

Glaxo: 4390 Libros DOCX

  1. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://ir.amicusrx.com/static-files/210fb8bd-b5d7-41e3-8adf-65d6e1d27446
  2.  
    Tipo: Microsoft Word

  3. 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. ...

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://investors.vrtx.com/static-files/59cd28b2-f8d9-4533-9bd4-48298ab0501e

  4. Uitdehaag et al. supplementary Table S1 Inhibitor name Marketed ...

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://journals.plos.org/plosone/article/file?type=supplementary&id=info:doi/10.1371/journal.pone.0092146.s009

  5. GlaxoSmithKline's

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://files.nc.gov/ncdps/documents/files/VOAD2020-Cover-Sheet.docx

  6. CONTACT: Jenni Walker – Walker PR Group – 980-339-8041-office ...

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    http://www.ncgskfoundation.org/assets/12212015_hmt_pr-5_heart-receives-glaxo-grant-approved.docx

  7. Template for Reports Developed

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0056469/bin/appd-et16.docx

  8. North Caroline GlaxoSmithKline Foundation

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    http://www.ncgskfoundation.org/assets/roh-budget-and-narrative-form-word-doc.docx

  9. Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ...

     
    Tipo: Microsoft Word
    Bakris 2006, Journal of Hypertension, GlaxoSmithKline, 5/7 (71%), 1/2 (50%), Rosiglitazone: GlaxoSmithKline (Avandia) and metformin: generic ... Table B5. Oral Hypoglycemic Agents: Data Abstraction: Study ....
    https://www.ncbi.nlm.nih.gov/books/NBK100623/bin/appb-et5.docx

Libro en otros formatos:


Arriba